Home208340 • KOSDAQ
add
PharmAbcine Inc
Previous close
₩2,915.00
Year range
₩2,520.00 - ₩3,970.00
Market cap
76.32B KRW
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 3.20B | 4,979.77% |
Operating expense | 2.93B | 69.75% |
Net income | 223.15M | 121.28% |
Net profit margin | 6.96 | 100.42% |
Earnings per share | — | — |
EBITDA | -2.37B | -63.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 43.35B | 128.65% |
Total assets | 54.29B | 103.36% |
Total liabilities | 6.60B | -34.74% |
Total equity | 47.69B | — |
Shares outstanding | 80.19M | — |
Price to book | 4.90 | — |
Return on assets | -12.08% | — |
Return on capital | -13.11% | — |
Cash Flow
Net change in cash
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 223.15M | 121.28% |
Cash from operations | -2.00B | -12.90% |
Cash from investing | 3.35B | -2.25% |
Cash from financing | -123.82M | -104.73% |
Net change in cash | 490.33M | -90.90% |
Free cash flow | -4.50B | -19.73% |
About
CEO
Founded
2008
Website
Employees
35
